Bonus BioGroup Ltd. (TLV:BONS)
23.50
0.00 (0.00%)
Oct 5, 2025, 2:48 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 274.46 million as of October 3, 2025. Its market cap has increased by 78.03% in one year.
Market Cap
274.46M
Enterprise Value
282.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
23.50
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 274.46M, an increase of 2,120.10%. That is a compound annual growth rate of 26.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 5, 2025 | 274.46M | 97.48% |
Dec 31, 2024 | 138.98M | -28.74% |
Dec 31, 2023 | 195.04M | -13.02% |
Dec 29, 2022 | 224.24M | -84.58% |
Dec 30, 2021 | 1.45B | 200.74% |
Dec 31, 2020 | 483.51M | 29.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 75.93B |
Danel (Adir Yeoshua) | 3.10B |
Kamada | 1.31B |
Bait Bakfar | 974.87M |
BrainsWay | 961.20M |
SofWave Medical | 943.38M |
Ilex Medical | 714.47M |
Novolog (Pharm-Up 1966) | 661.07M |